← Eichor
Study identifier: NCT07218380 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Condition: Carcinoma, Transitional Cell · Urinary Bladder Neoplasms · Neoplasm Metastasis  ·  Sponsor: Eli Lilly and Company

PhasePhase 3
Planned participants450
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to test a new medicine, vepugratinib, in comparison with placebo, to see if it is safe and can help people with a bladder cancer that is advanced or has spread. Vepugratinib or placebo will be administered in combination with enfortumab vedotin and pembrolizumab. Study participation could last up to approximately 6 years.

This description comes directly from the study's public registry record.

Talk to the study team

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or  ·  1-317-615-4559  ·  LillyTrials@Lilly.com

Physicians interested in becoming principal investigators please contact  ·  clinical_inquiry_hub@lilly.com

Always discuss trial participation with your own doctor first.

Locations (286)

Clearview Cancer InstituteHuntsville, Alabama, United StatesRecruiting
The University of Arizona Cancer Center - North CampusTucson, Arizona, United StatesNot Yet Recruiting
University of Arkansas for Medical SciencesLittle Rock, Arkansas, United StatesNot Yet Recruiting
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - IrvineIrvine, California, United StatesNot Yet Recruiting
TRIO-US (Translational Research in Oncology-US)Los Angeles, California, United StatesNot Yet Recruiting
UCLA Hematology/Oncology - Santa MonicaLos Angeles, California, United StatesRecruiting
University of California, Irvine (UCI) Health - UC Irvine Medical CenterOrange, California, United StatesNot Yet Recruiting
University of California Davis (UC Davis) Comprehensive Cancer CenterSacramento, California, United StatesNot Yet Recruiting
UCSF Medical Center at Mission BaySan Francisco, California, United StatesRecruiting
Hunt Cancer Institute, an Affiliate of Cedars-Sinai Cancer (TMPN)Torrance, California, United StatesRecruiting
AdventHealth Medical Group - PorterDenver, Colorado, United StatesNot Yet Recruiting
Colorado West Healthcare System - Grand Valley OncologyGrand Junction, Colorado, United StatesRecruiting

+ 274 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07218380